/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Cavalry Biosciences

Cavalry Biosciences

San Francisco, United States

Cavalry Biosciences develops precision medicines based on IGF-1, a growth factor, to treat various diseases

Healthcare & Biotech

Cavalry Biosciences, based in San Francisco, United States, has 2 investors on file, among them Kerna Ventures and Mission BioCapital. Its latest round on record is Series B, 8 Jun 2026. Its site was last checked 13 Nov 2026: site answers.

cavalry.bio

Funding

1 round on record
Latest roundSeries B8 Jun 2026
Since that round5 monthsno later round on record
Investors in its rounds1none with a VCinfo profile yet
Jun 2026Series B1 investor named

Round sizes and total raised are on Fundup AI, our sister product for funding data.

Investors

2 investors on file
InvestorEvidenceType
Kerna VenturesPortfolio pageVenture capital
Mission BioCapitalPortfolio pageVenture capital

More from Kerna Ventures

13 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (92%), Real Estate & Construction (8%).

AerskaAerska develops RNA medicines to treat diseases of the brainAptaDirAptaDir develops RNA-based therapeutics to reprogram DNA methylation i…BreezeBioBreezeBio is solving the problem of targeted delivery of genetic medic…Epicrispr BiotechnologiesEpicrispr Biotechnologies develops therapies to dynamically control ge…RougeTxRougeTx is developing small-molecule therapies to restore vascular sta…

See Kerna Ventures' full profile · Who invests alongside it

More from Mission BioCapital

52 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (90%), AI & Machine Learning (4%), E-commerce & Marketplaces (2%).

AI ProteinsThe company designs and develops a new class of miniprotein medicines …AlectorAlector develops therapies for neurodegenerative diseasesBolt ThreadsThe company pioneers and manufactures biomaterials to create high-qual…Breye TherapeuticsBreye Therapeutics develops novel, orally administered ophthalmology d…Caribou BiosciencesCaribou Biosciences is a clinical-stage biopharmaceutical company focu…

See Mission BioCapital's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Cavalry Biosciences and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Kerna Ventures adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/cavalry.bio/investors

# also
GET /v1/companies/cavalry.bio
GET /v1/companies/cavalry.bio/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing